The Reducing Antipsychotics in People with Intellectual Disability (RAPID) project aims to reduce harm from antipsychotic medication prescribing to adults with intellectual disability.

Antipsychotic medications, designed to treat serious mental illness including schizophrenia, are often used for control of behaviour in people with intellectual disability.  This practice is largely unsupported by evidence, and associated with harm.  There is currently little research to inform service delivery on deprescribing antipsychotic and medications to Australians with intellectual disability. Inappropriate prescribing causes harm, so the proposed project will have a significant impact on the health and wellbeing of people with intellectual disability.

This is a pilot project to trial the efficacy of a protocol to reduce the inappropriate use of antipsychotic medications. 

The project is funded by the Endeavour Foundation Disability Research Fund.

Join our Advisory Committee

The research team are currently looking for people with intellectual and developmental disability and their support people to join the project's advisory committee.

Advisory committee members will help the researchers make the project better for people with intellectual and developmental disability. They might talk about how to make information easier to understand. Or talk about how to run the project so it's easier for people with intellectual and developmental disability to be involved. 

To join the advisory group, people will need to be over 18 and able to attend up to 4 meetings in 2020. 

Contact David Harley or Shamshad Karatela if you're interested!